Citadel Advisors
AMSG

Citadel Advisors’s Amsurg Corp AMSG Stock Holding History

Citadel Advisors’s Portfolio AMSG Stock Details AMSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,300
Closed -$624K – 8322
2016
Q3 		$624K Sell
9,300
-1,100
-11% -$76.9K ﹤0.01% 4512
2016
Q2 		$806K Sell
10,400
-3,300
-24% -$255K ﹤0.01% 3846
2016
Q1 		$1.02M Sell
13,700
-3,400
-20% -$239K ﹤0.01% 3461
2015
Q4 		$1.3M Buy
17,100
+800
+5% +$63.3K ﹤0.01% 3270
2015
Q3 		$1.27M Buy
16,300
+8,700
+114% +$671K ﹤0.01% 3508
2015
Q2 		$532K Buy
+7,600
New +$508K ﹤0.01% 4866

Other funds holding AMSG

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Citadel Advisors's AMSG Position: Q4 2016 in Review

Citadel Advisors sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 694,657 shares — an estimated $46.6M sold.

Citadel Advisors first reported a position in AMSG in Q2 2013 and held it in 13 quarters. The position peaked at $46.6M in Q3 2016. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

  • Citadel Advisors reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
  • Citadel Advisors sold 694,657 Amsurg Corp shares in Q4 2016, an estimated $46.6M.
  • Citadel Advisors first reported a position in Amsurg Corp in Q2 2013 and held it in 13 quarters.
  • Citadel Advisors's Amsurg Corp position peaked at $46.6M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.